Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
15%
Ph phase_1
10
77%
Ph phase_2
1
8%

Phase Distribution

10

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
10(76.9%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(13)

Detailed Status

Completed13

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 110 (76.9%)
Phase 21 (7.7%)
Phase 32 (15.4%)

Trials by Status

completed13100%

Recent Activity

0 active trials
Showing 5 of 13
completedphase_3

A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

NCT01192867
completedphase_1

A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers

NCT01543529
completedphase_1

A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy Volunteers

NCT01365403
completedphase_1

A Study of the Relative Bioavailability of Single Dose RO4917838 and the Effect of Food in Healthy Volunteers

NCT01665976
completedphase_1

A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users

NCT01438749
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT01192867Phase 3

A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

Completed
NCT01543529Phase 1

A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers

Completed
NCT01365403Phase 1

A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy Volunteers

Completed
NCT01665976Phase 1

A Study of the Relative Bioavailability of Single Dose RO4917838 and the Effect of Food in Healthy Volunteers

Completed
NCT01438749Phase 1

A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users

Completed
NCT01613040Phase 1

A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers

Completed
NCT01433575Phase 1

A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers

Completed
NCT01356550Phase 1

A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838

Completed
NCT01510899Phase 1

A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838

Completed
NCT01495104Phase 1

A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy Volunteers

Completed
NCT01116830Phase 1

A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder

Completed
NCT01235520Phase 3

A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

Completed
NCT00616798Phase 2

A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13